{"hands_on_practices": [{"introduction": "Understanding dosage compensation begins with a simple but powerful rule. To balance the expression of X-linked genes between sexes, mammals inactivate all but one of their X chromosomes. This practice exercise [@problem_id:1484343] challenges you to apply this fundamental \"N-1\" rule to a hypothetical, but conceptually clear, scenario involving a cell with an unusual number of chromosomes. Mastering this basic calculation is the first step toward diagnosing and understanding the consequences of various X-chromosome aneuploidies.", "problem": "In mammalian somatic cells, a process known as dosage compensation ensures that the expression levels of genes on the X chromosome are balanced between males (XY) and females (XX). This is achieved through the inactivation of one of the X chromosomes in females, which condenses to form a compact, transcriptionally inactive structure called a Barr body. This mechanism generally follows the rule that all but one X chromosome in a somatic cell are inactivated.\n\nConsider a rare case of a human tetraploid somatic cell, which contains four complete sets of chromosomes. The specific karyotype of this cell is found to be $92,XXXX$. Assuming the standard mechanism of X-inactivation applies, determine the number of Barr bodies that would be expected to be observed in the nucleus of this cell during interphase.", "solution": "Dosage compensation in mammalian somatic cells operates by inactivating all but one X chromosome. Let $N_{X}$ denote the number of X chromosomes present in the nucleus. The number of inactive X chromosomes, each visible as a Barr body during interphase, is therefore\n$$\nB = N_{X} - 1 \\quad \\text{for} \\quad N_{X} \\ge 1.\n$$\nFor the given tetraploid karyotype $92,XXXX$, the number of X chromosomes is $N_{X} = 4$. Substituting into the rule gives\n$$\nB = 4 - 1 = 3.\n$$\nThus, three Barr bodies are expected.", "answer": "$$\\boxed{3}$$", "id": "1484343"}, {"introduction": "Moving beyond simple counting, we now explore the molecular machinery that drives X-inactivation. The process is not magic; it is controlled by a specific genetic locus, the X-Inactivation Center, and its key gene, *XIST*. This problem [@problem_id:1484351] presents a scenario where one X chromosome has a defective *XIST* gene, forcing you to predict the outcome. By working through this, you will gain a deeper appreciation for how a single gene's function is essential for chromosome-wide regulation and cellular survival.", "problem": "In human females, dosage compensation for X-linked genes is achieved by the inactivation of one of the two X chromosomes in somatic cells, a process that forms a visible Barr body. This inactivation is initiated by a region on the X chromosome called the X-Inactivation Center (XIC), which contains the *XIST* (X-inactive specific transcript) gene. The *XIST* gene produces a non-coding RNA that coats the chromosome from which it is transcribed, leading to its condensation and silencing.\n\nConsider a female individual with a rare chromosomal constitution. Her karyotype is found to be $46,X,r(X)$, meaning she has one normal X chromosome and one ring X chromosome, denoted $r(X)$. Detailed genetic analysis reveals that the ring X chromosome, $r(X)$, has a deletion that completely removes the *XIST* gene locus, while the normal X chromosome is structurally and genetically intact. Assuming that survival of the cell requires proper dosage compensation (i.e., the inactivation of one X chromosome), which of the following statements most accurately predicts the outcome of X-inactivation in this individual's somatic cells?\n\nA. The normal X chromosome will be preferentially inactivated in all somatic cells.\n\nB. The ring X chromosome, $r(X)$, will be preferentially inactivated in all somatic cells because it is abnormal.\n\nC. Inactivation will be random, with some cells inactivating the normal X and other cells inactivating the ring X.\n\nD. Neither X chromosome will be inactivated, resulting in cells with a double dose of most X-linked genes.\n\nE. Both X chromosomes will be partially inactivated to compensate for the abnormal chromosome structure.", "solution": "Principle of X-chromosome inactivation: In mammalian females, dosage compensation is achieved by inactivating one X chromosome per somatic cell. Initiation requires the X-Inactivation Center (XIC), which includes the gene $XIST$. $XIST$ produces a non-coding RNA that acts in cis to coat the chromosome from which it is transcribed, initiating its condensation and silencing. The chromosome that expresses $XIST$ becomes the inactive X (Barr body). A chromosome lacking a functional $XIST$ locus cannot initiate its own inactivation.\n\nGiven karyotype $46,X,r(X)$ with one normal X and one ring X, and the ring X has a deletion completely removing the $XIST$ locus:\n1. The $r(X)$ cannot express $XIST$, so it cannot be inactivated in cis. Therefore, it is not a viable candidate for the inactive X.\n2. The cellular counting mechanism still requires that one X be inactivated for proper dosage compensation. With two X chromosomes present, the system will initiate inactivation on a chromosome capable of doing so.\n3. The only chromosome capable of inactivation is the normal X, which retains an intact XIC and $XIST$. Thus, the normal X will express $XIST$, be coated by its RNA, and become the inactive X (Barr body).\n4. This choice occurs early in development and is clonally propagated, so somatic cells will show skewed inactivation, with the normal X preferentially inactivated in essentially all cells.\n\nEliminating the options:\n- B is incorrect because $r(X)$ lacks $XIST$ and cannot be inactivated despite being structurally abnormal.\n- C is incorrect because random choice requires both X chromosomes to be competent for inactivation; here only the normal X is competent.\n- D is incorrect because the counting mechanism enforces inactivation of one X, and the normal X can fulfill this.\n- E is incorrect because X-inactivation is not partial on both chromosomes; it is an all-or-none cis process requiring $XIST$ on the inactivated chromosome.\n\nTherefore, the normal X will be preferentially inactivated in all somatic cells.", "answer": "$$\\boxed{A}$$", "id": "1484351"}, {"introduction": "The principles of X-chromosome inactivation are not just textbook concepts; they are powerful tools used in modern biomedical research. Because the choice of which X chromosome to inactivate is random in each cell during early development, females are natural mosaics for their X-linked genes. This final practice [@problem_id:1484361] illustrates how this mosaicism can be used to answer critical questions in cancer biology, such as determining whether a tumor grew from a single cell or multiple cells. This quantitative exercise connects a fundamental genetic principle to a practical application in disease analysis.", "problem": "A researcher is studying the origin of a tumor in a female mammal. This individual is heterozygous for an X-linked housekeeping gene, *GENEX*. The two alleles present are *GENEX-A* and *GENEX-B*, which produce distinct mRNA transcripts. As a baseline, an analysis of healthy somatic tissue from this individual confirms that, due to random X-chromosome inactivation, the total population of *GENEX* mRNA transcripts is composed of 50.0% *GENEX-A* transcripts and 50.0% *GENEX-B* transcripts.\n\nThe researcher hypothesizes that the tumor is monoclonal, meaning it arose from a single progenitor cell. In this specific case, it is assumed that the progenitor cell had its X-chromosome carrying the *GENEX-B* allele inactivated, and this inactivation pattern was stably inherited by all subsequent tumor cells. A biopsy is taken, and it consists of a mixture of these monoclonal tumor cells and contaminating healthy somatic cells.\n\nAn analysis of the total mRNA extracted from the entire biopsy sample reveals that 72.0% of the *GENEX* transcripts are of the *GENEX-A* type and 28.0% are of the *GENEX-B* type. Assuming that the per-cell expression level of the *GENEX* gene is identical in both tumor and healthy cells, calculate the fraction of cells in the biopsy that are tumor cells. Express your answer as a decimal rounded to three significant figures.", "solution": "Let $f$ denote the fraction of cells in the biopsy that are tumor cells. Assume each cell contributes the same total number of *GENEX* transcripts (call this per-cell total $E$), as stated.\n\n- In tumor cells, the X chromosome carrying $GENEX\\text{-}B$ is inactivated, so only $GENEX\\text{-}A$ is expressed. Thus, each tumor cell contributes $E$ $GENEX\\text{-}A$ transcripts and $0$ $GENEX\\text{-}B$ transcripts.\n- In healthy cells, due to random X inactivation and heterozygosity, half of the cells express $GENEX\\text{-}A$ and half express $GENEX\\text{-}B$, so on average each healthy cell contributes $\\frac{E}{2}$ $GENEX\\text{-}A$ transcripts and $\\frac{E}{2}$ $GENEX\\text{-}B$ transcripts.\n\nConsider a biopsy with a large number $N$ of cells. Then:\n- Total $GENEX\\text{-}A$ transcripts from tumor cells: $f N \\cdot E$.\n- Total $GENEX\\text{-}A$ transcripts from healthy cells: $(1-f) N \\cdot \\frac{E}{2}$.\nHence, the total $GENEX\\text{-}A$ transcripts are $N E\\left(f + \\frac{1-f}{2}\\right)$.\n\nThe total *GENEX* transcripts (A plus B) from all cells equal $N E$ (since each cell contributes $E$ in total). Therefore, the fraction of $GENEX\\text{-}A$ transcripts in the biopsy is\n$$\n\\frac{N E\\left(f + \\frac{1-f}{2}\\right)}{N E}\n= f + \\frac{1-f}{2}\n= \\frac{1}{2} + \\frac{f}{2}.\n$$\nThe measured $GENEX\\text{-}A$ fraction is $0.72$, so\n$$\n\\frac{1}{2} + \\frac{f}{2} = 0.72\n\\;\\;\\Rightarrow\\;\\;\n\\frac{f}{2} = 0.22\n\\;\\;\\Rightarrow\\;\\;\nf = 0.44.\n$$\nRounded to three significant figures, the fraction of tumor cells is $0.440$.", "answer": "$$\\boxed{0.440}$$", "id": "1484361"}]}